You just read:

Enrollment in Phase 1/2a Study of IONIS-HTT Rx in Patients with Huntington's Disease Completed and Open-Label Extension Study to Open in 2H 2017

News provided by

Ionis Pharmaceuticals, Inc.

Jun 22, 2017, 07:00 ET